Considerations on the Off-Label Use of Ketamine as a Treatment for Mood Disorders
Wilkinson ST, Sanacora G. Considerations on the Off-Label Use of Ketamine as a Treatment for Mood Disorders. JAMA 2017, 318: 793-794. PMID: 28806440, PMCID: PMC6248331, DOI: 10.1001/jama.2017.10697.Commentaries, Editorials and LettersAdvisory CommitteesAnesthetics, DissociativeChronic DiseaseHumansKetamineMood DisordersOff-Label Use